Search

Human prion diseases are a group of rare and fatal neurodegenerative diseases that include idiopathic (sporadic), genetic (inherited), and acquired (infectious) disorders (1). All are associated with the accumulation of [...]

Plasma polymer thin coatings can be used in a variety of applications that require thin ultrasmooth, defect-free homogeneous films. In this study both film formation and crack development are described and related to the structure of the plasma polymer. The growth of a plasma polymer film reproduces the topography of the porous (polysulfone) PSf support and the time needed for complete coverage depends on the rate of deposition which is a function of the plasma power and monomer flow rate. The plasma polymerized hexamethyldisiloxane, PPHMDSO, film on a PSf porous support is under compressive internal stress causing the membrane to bend convexly with respect to the film. Despite these stresses, the composite membrane (film/support) did not crack when freely immersed in water and alcohols. Cracks developed in the mechanically constrained PPHMDSO composite membrane on exposure to alcohols. Films with more organic character showed high adhesion among the plasma polymer nodules and between the plasma polymer and the PSf substrate, resulting in substrate tearing and cracking straight through the plasma polymer layer., INTRODUCTION Thin, pinhole-free films can be formed on a variety of substrates through plasma polymerization. Almost any organic gas or vapor can be used as a 'monomer' for plasma polymerization [...]

Creatine (Cr)(3) is an important component of the energy delivery process in tissues with a high and/or fluctuating energy demand. In the phosphorylated form, phosphocreatine (PCr) is directly involved in maintaining low adenosine diphosphate concentrations at the sites of energy utilization. Consequently, the maintenance of an adequate supply of PCr at the contractile site of the muscle is important for the perpetuation of muscle performance during intense exercise and exertion. In normally active animals and humans, a sufficient supply of PCr is considered to be synthesized from the amino acids arginine and glycine (Harris and Lowe 1995). It has been observed in humans, however, that supplementary dietary Cr can, over time, increase the normal muscle content of 100-130 mmol/kg dry weight by between 2 and 40 mmol/kg (Harris et al. 1992). Dietary Cr supplementation has been shown to have a positive effect on short-lasting maximal exercise performance and sustained intense exercise with reduced metabolic effort (Balsom et al. 1993, Greenhaff et al. 1993, Harris et al. 1993); therefore, such Cr loading might be considered beneficial to the working and/or sporting dog. In the wild, the intake of Cr by the dog from freshly killed prey can be regular and substantial, 1.23-3.0 mmol/(kg body weight [center dot] d) (Rohrs 1987). However, a recent review of the dietary intake of Cr in the domestic dog indicated that dietary supply may be limited (Harris et al. 1997). Although this should not be regarded as a deficiency of the diet, it is certainly possible that an increase in supply may influence performance as with human athletes. A recent study in humans showed that long-term, low dose supplementation of the diet with Cr was ultimately as effective in raising muscle Cr concentration as a short-term, high dose supplementation (Hultman et al. 1996). In dogs, it has been shown that Cr is equally well absorbed into the plasma from either fresh meat or synthetic Cr (Harris and Lowe 1995). It remains unknown, however, which of the feeding regimens is the most appropriate to maximize muscle Cr concentration in dogs. A preliminary study was therefore conducted to investigate the effect of increasing dietary supplemental Cr on muscle and plasma Cr concentrations in dogs before a further more detailed study of the accumulation of muscle Cr over time. Materials and methods. Twelve adult Beagle dogs (13.7 kg, SD 2.59) were housed in 2.4 [m.sup.2] (1.7 m x 1.4 m) concrete block pens with an open-mesh steel gate to the front allowing them visual access to kennel-mates and the central walkway/exercise area. Bedding was provided in the form of soft-wood shavings. The kennel building was heated and ventilated to maintain a temperature between 16 and 24 [degrees], 30-70 % relative humidity with 12 h of light in a 24-h period. All dogs were monitored throughout the day and pens cleaned once daily. The study protocols were appropriately approved and the animals maintained under the care of a veterinary surgeon for the duration of the study in compliance with the 1986 EC directive (86/609/EEC) regarding the protection of animals used for experimental and other scientific purposes. All dogs had been fed a basal diet (Lowe et al. 1994), which contained 0.156 mmol Cr/kg diet for at least 2 mo. The dogs were then randomly allocated to four treatment groups (n = 3 per group) and the diet supplemented with dry crystalline creatine monohydrate to provide the equivalent of 0.38, 0.76, 1.53 or 3.05 mmol Cr/kg body weight daily for 28 d. Muscle biopsy samples were taken under anesthesia from the biceps femoris muscle of each dog using a percutaneous needle biopsy technique on d 0 (the day preceding Cr supplementation), 14 and 28; samples were frozen immediately. Subsequently, the samples were freeze-dried, dissected from visible connective tissue, powdered and analyzed for Cr, creatinine (Cn) and PCr, using reverse-phase ion-pairing high performance liquid chromatography (Dunnett et al. 1991). Blood samples were taken immediately before feeding and then at 0.5, 1, 2, 3, 4 and 5 h after feeding on d 0, 14 and 28. All samples were immediately centrifuged and the plasma separated and frozen for subsequent Cr and Cn analysis. Plasma Cr and Cn were analyzed by ANOVA using the area under the plasma curve for 5 h after feeding ([AUC.sub.5]) within each collection day. With the use of ANOVA, muscle Cr concentration was examined by regression on Cr intake within a sample day. It is acknowledged that simple ANOVA between the two chosen time points is inappropriate; therefore, changes in muscle Cr concentration over time within the experiment were examined by a regression model. Results. Significant differences were observed in the [AUC.sub.5] for plasma Cr on d 14 (P = 0.009) and on d 28 (P = 0.005) (Table 1). The 1.53 and 3.05 mmol/kg treatments substantially increased the [AUC.sub.5] and peak plasma values for Cr. The profiles for plasma Cr were similar in shape for both d 14 and 28. Curves for the pooled data are shown for illustration in Figure 1. The plasma Cn profile for each treatment closely followed the plasma Cr profile with no apparent time lag. Although the plasma Cn profile was similar in shape, there was greater variability in value. There was a correlation between the [AUC.sub.5] for plasma Cn and the [AUC.sub.5] of Cr, which could be explained by the following equation: Plasma Cn = [0.32(SEM = 0.096) x Plasma Cr] - 21.1(SEM = 47.32) R = 0.81 The concentrations of the individual components, Cr, PCr and Cn found in the muscle samples were different from that expected to be found in vivo. In all probability, this is due to the likely hydrolysis of PCr during sample collection and preparation. The data were therefore analyzed on the basis of the total PCr + Cr + Cn, termed TCr, in the muscle sample. The TCr found in the muscles of supplemented dogs was within the range found in the muscles of Cr-supplemented humans. Variation in sample adenosine triphosphate (mean 23.9 [+ or -] 0.45 mmol/kg) indicated that the samples were consistent in their muscle content and did not account for any differences seen in TCr among dogs. Numerical increases, on the order of 8-32 mmol/kg in muscle TCr were observed within individual dogs from d 0 to 14. Further increases on d 28 were not observed, and no consistent effect over time for any treatment could be established. The mean values for each day and treatment are shown in Table 2. Large between-animal variation was observed both pre- and post-treatment, which, together with the small sample size, accounted for the overall large P-values reported for the treatment effects. Dogs with low initial muscle TCr increased their muscle TCr concentration more than those with higher initial muscle TCr concentrations. Within a given day, there were between-treatment differences, with the 3.05 mmol/kg treatment producing consistently lower muscle Cr values. Elimination of the dogs (n = 3) with high (>140 mmol/kg) initial muscle TCr concentrations from the data resulted in a more dramatic treatment effect by reducing the mean and the variability (SEM) of the TCr in the control dogs from 128.6 [+ or -] 17.19 to 111.7 [+ or -] 5.2. This resulted in a more definite effect of Cr intake on muscle Cr concentration, (Table 3). The observed increase, similar to that in humans (Hultman et al. 1996), is likely to be sufficient to account for the improvement in lactate threshold observed in dogs fed dietary supplemental Cr (Lowe, unpublished observations). Discussion. The data indicate that there may be large differences in muscle TCr concentration in dogs despite a constant dietary supply. The effect of feeding dietary supplemental Cr over a 4-wk period is to increase the muscle TCr of those dogs with low ( KEY WORDS: * dogs * creatine * muscle * plasma * creatinine

A pulsed vacuum arc deposition technique, based on a magnetic macroparticle filter producing vacuum arc discharges, aids the formation of macroparticle-free thin films of many materials. There is total symmetry between the magnetic field and the plasma production, because the arc current drives the magnetic field. Plasma flows through a macroparticle filter aided by the axial magnetic field.